Barclays Sticks to Their Hold Rating for Smith & Nephew (SN)
In a report released today, Hassan Al-Wakeel from Barclays maintained a Hold rating on Smith & Nephew, with a price target of £13.05.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Al-Wakeel is ranked #10990 out of 12163 analysts.
Currently, the analyst consensus on Smith & Nephew is a Moderate Buy with an average price target of p1,460.57.
Based on Smith & Nephew’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p3.31 billion and a net profit of p342.47 million. In comparison, last year the company earned a revenue of p2.98 billion and had a net profit of p198 million
Based on the recent corporate insider activity of 76 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of SN in relation to earlier this year.
Read More on GB:SN:
Disclaimer & DisclosureReport an Issue
- Smith & Nephew price target lowered to $32 from $35 at Canaccord
- Smith & Nephew announces evidence for Cartiheal Agili-C Cartilage Repair
- Smith & Nephew: Entering a Faster Growth Phase with Re-Rating Potential on Conservative Guidance
- Smith & Nephew reports positive trial data for Regeneten implant
- Smith & Nephew price target raised to 1,507 GBp from 1,482 GBp at Morgan Stanley
